Guardant Health, Inc.
GH
$85.49
$1.471.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.88% | 30.38% | 28.74% | 28.20% | 31.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.88% | 30.38% | 28.74% | 28.20% | 31.04% |
| Cost of Revenue | 20.43% | 19.07% | 19.45% | 25.06% | 27.64% |
| Gross Profit | 40.91% | 37.82% | 34.95% | 30.27% | 33.34% |
| SG&A Expenses | 29.61% | 30.24% | 34.69% | 27.09% | 20.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.03% | 19.62% | 20.25% | 16.88% | 13.07% |
| Operating Income | 1.42% | -2.35% | -7.46% | -1.58% | 7.99% |
| Income Before Tax | 4.03% | 22.40% | 15.81% | 9.71% | 9.12% |
| Income Tax Expenses | -198.36% | 4,270.37% | 120.53% | 37.53% | 87.45% |
| Earnings from Continuing Operations | 4.61% | 22.17% | 15.68% | 9.62% | 8.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.61% | 22.17% | 15.68% | 9.62% | 8.98% |
| EBIT | 1.42% | -2.35% | -7.46% | -1.58% | 7.99% |
| EBITDA | 0.91% | -3.29% | -8.80% | -2.08% | 8.66% |
| EPS Basic | 6.77% | 24.16% | 18.24% | 13.87% | 16.91% |
| Normalized Basic EPS | 0.17% | -2.33% | -6.15% | 6.65% | 21.03% |
| EPS Diluted | 6.77% | 24.16% | 18.24% | 13.87% | 16.91% |
| Normalized Diluted EPS | 0.17% | -2.33% | -6.15% | 6.65% | 21.03% |
| Average Basic Shares Outstanding | 2.14% | 2.23% | 2.99% | 5.65% | 9.66% |
| Average Diluted Shares Outstanding | 2.14% | 2.23% | 2.99% | 5.65% | 9.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |